Portfolio Analysis in Leuven.

A patent portfolio analysis Leuven deep-tech teams can act on starts where this city’s economy does — with imec and KU Leuven, two engines that make Leuven one of Europe’s densest patenting clusters per capita. Imec, founded here in 1984, is the world’s largest independent research centre for nanoelectronics and digital technology, running more than 12,000 square metres of semiconductor cleanroom and a patent portfolio of over 1,600 families. KU Leuven Research & Development (LRD), one of Europe’s first technology-transfer offices, has spun out more than 180 companies from the university’s estate. For a research institute, a spin-out founder or an in-house counsel here, the questions asked of a patent estate are specific: how strong are the chip, sensor and life-science families, where does freedom to operate run into enormous rival assignees, and what is the estate worth to a licensee or an investor?

The work is landscape, gap, strength and valuation analysis — not litigation. It is the freedom-to-operate map behind a new process node or sensor, the diligence pack behind a spin-out’s Series A, and the pruning decision that stops a large estate overspending at the OPRI and the EPO. It also has to read one fact that changes everything about Belgian strategy: Belgium is a founding member of the Unified Patent Court, with a Local Division in Brussels. PerspireIP builds those studies for the semiconductor, nanoelectronics, photonics and biotech portfolio owners across Leuven and the wider Flemish Brabant region.

Why patent portfolio analysis Leuven owners frame around imec and KU Leuven

In most cities a portfolio review begins with a product line. In Leuven it begins with a research institute. This is a deep-tech cluster built around two anchors: imec, the world’s largest independent research and innovation centre for nanoelectronics and digital technology, headquartered here since 1984 with more than 5,500 researchers from over 90 countries; and KU Leuven, whose technology-transfer office, KU Leuven Research & Development (LRD), has operated since 1972 and is one of the oldest in Europe. A patent portfolio analysis Leuven owners can use has to read an estate the way these organisations do — as leverage in licensing and collaboration, not as an abstract count of granted claims.

That framing changes the deliverable. Much of Leuven’s IP is co-owned: imec reports that many of its 1,600-plus patent families are held jointly with universities and industrial partners, and LRD manages the university’s portfolio alongside a web of research contracts and spin-out assignments. So the study has to trace ownership and encumbrance before it grades strength, map freedom to operate across huge semiconductor assignees, and separate the families that genuinely protect a differentiator from the long tail that only costs renewal fees. We build analysis a research-programme lead, an IP counsel or a corporate-development team can act on, tied to the licensing round, financing or budget cycle that prompted it.

• Ownership and encumbrance mapping — who actually owns each co-invented family, and what research or consortium contracts constrain it
• FTO clearance — freedom-to-operate landscaping before a new process node, sensor or platform ships
• Licensing and collaboration leverage — which families carry weight in a joint-development or cross-licence negotiation
• Board and budget reviews — a periodic strength, gap and renewal-cost picture for the CTO and general counsel

imec-scale semiconductor and nanoelectronics freedom-to-operate

Here is the fact that reshapes any semiconductor estate review in Leuven. Advanced-node chip and nanoelectronics inventions sit inside some of the most crowded patent landscapes in the world, fenced by enormous assignees — the global foundries, equipment makers and IDMs whose portfolios run to tens of thousands of families each. For a Leuven fabless start-up, a materials supplier or a sensor spin-out, freedom to operate is rarely a matter of a handful of references; it is a landscape exercise across process, device, packaging, photonics and design-IP layers, any one of which can carry a blocking claim.

Standards add a second dimension. Chips that touch connectivity, memory interfaces or beyond-5G communications can read on standard-essential patents held by third parties, so the review has to flag where a product implements a declared standard and where inbound royalty exposure could follow. We map the assignees that dominate each layer of your stack, identify the families most likely to read on your process and device architecture, and grade whatever essentiality your own patents might carry — because declared-essential is rarely the same as truly essential, and a few genuinely essential families can materially change a licensing conversation.

A patent portfolio analysis Leuven semiconductor owners rely on treats FTO and strength as two sides of one map. The same landscape that shows where a rival could block your product also shows the white space a filing programme should push into next — the device, materials, packaging or photonics inventions competitors have not yet fenced off. For a deep-tech estate that distinction is worth real money: it tells you which crown-jewel families to defend and extend, and which legacy filings to let lapse before the next annuity falls due.

KU Leuven LRD spin-out diligence and valuation for a raise

Leuven’s other great source of patent value is the spin-out. Since 1972, LRD’s support — a multidisciplinary team of legal counsels, patent experts and investment managers — has helped create more than 180 companies from KU Leuven research, employing over 7,700 people. These ventures share a common trait: the whole valuation can rest on one or two foundational patent families, whether that is a chemical-recycling process, an emulsion technology, a diagnostic or a chip-design block. When such a company raises capital or fields an acquisition offer, the estate is the asset a buyer or investor scrutinises first.

Spin-out diligence is a different discipline from grading a mature estate. The first questions are legal rather than technical: does the company actually own the patents, or does the university, imec or a consortium retain rights; is the assignment chain clean; are there licence-backs, field-of-use limits or research exemptions buried in the founding agreements? Only once ownership is settled does it make sense to confirm the claims cover the technology, map the competitive landscape, and test whether the families would survive an EPO opposition or a validity attack. We deliver that as data-room-ready exhibits, typically inside the raise or deal window.

A patent portfolio analysis Leuven founders and investors trust reads each estate on its own terms. A nanoelectronics spin-out may carry one platform patent that underwrites its whole story; a biotech a single composition-of-matter family; a photonics venture a handful of device patents. Counting filings tells you nothing useful about any of them — grading each against products, competitors, ownership and validity risk tells you everything you need to raise, sell or defend a budget.

Belgium is a UPC member: the Brussels Local Division posture

This is where a Belgian estate diverges sharply from one in a non-UPC country. Belgium is a founding contracting member of the Unified Patent Court, which opened on 1 June 2023, and it hosts a Local Division in Brussels on the premises of the FPS Economy. A single UPC action can injunct or revoke a European patent with unitary effect across every participating member state at once — enormous leverage for a well-built Leuven portfolio, and equally enormous exposure to a rival’s central attack. An estate sitting in a non-UPC jurisdiction simply does not carry that pan-European reach or that single point of failure.

The Brussels Local Division has a feature no other division shares: it can conduct proceedings in four languages — Dutch, German, French and English — which matters for a bilingual country and for international deep-tech parties. It sits with the permanent Belgian judge, Sam Granata, alongside judges from other member states. For a portfolio owner, the practical question is forum posture: where a Brussels-seated action would sit against a competitor’s home division, and whether an English-language proceeding on home ground is an advantage worth designing for before a dispute rather than during one.

Every family therefore needs a deliberate UPC stance. A classic European patent can be opted out of the court’s jurisdiction during the transitional period, or left in to keep pan-European enforcement available; a unitary patent is locked into the UPC by design. We grade each asset for opt-out or opt-in, flag the crown-jewel families worth defending centrally and the vulnerable ones better withdrawn, and read how a Brussels Local Division strategy fits the rest of a European estate.

The Brussels Enterprise Court and the national-versus-UPC choice

For purely national disputes, Belgium funnels every patent case into one specialist forum. The Brussels Enterprise Court (Ondernemingsrechtbank Brussel / Tribunal de l’entreprise de Bruxelles) holds exclusive jurisdiction over patents for the entire Belgian territory, so infringement and validity of a Belgian national patent are decided in a single court applying a single, coherent body of case law. For a portfolio owner that means national precedent on validity and claim construction is consistent, and an estate can be graded against one settled forum rather than a patchwork of regional courts.

The interesting complication is the overlap with the UPC. For the Belgian part of a European patent, a right-holder currently retains a choice — during the transitional period running to 2030 — between bringing the action before the Brussels Enterprise Court and bringing it before the Unified Patent Court. That choice interacts directly with each patent’s opt-out status: opting a European patent out of the UPC pushes any Belgian dispute back toward the Enterprise Court, while leaving it in keeps the UPC route open. Getting that combination wrong on a crown-jewel family can quietly forfeit the forum you would most want.

A patent portfolio analysis Leuven counsel can rely on reads both tracks together. We map, family by family, which assets are Belgian national patents that can only ever be litigated in the Brussels Enterprise Court, which are European or unitary patents exposed to the UPC, and where the opt-out and transitional-period choices leave a given asset. That forum map is portfolio intelligence for the negotiating table and the budget line, not a litigation brief.

OPRI, the EPO route, PCT filing and renewal pruning

Most Leuven estates blend national and European routes, and a review has to price each correctly. The Belgian Office for Intellectual Property — OPRI in French, DIE in Dutch, part of the Federal Public Service Economy in Brussels — grants Belgian national patents and manages the national register. The bulk of protection for a deep-tech portfolio, though, arrives through the European Patent Office, validated country by country or, since June 2023, as a unitary patent giving single-title coverage across the participating states, Belgium included. Which route a family took shapes both its cost profile and where it can be enforced.

There is a filing-route detail specific to Belgium that a review should flag. Since 1 April 2018 the OPRI no longer acts as a receiving office for international applications under the Patent Cooperation Treaty, so Belgian applicants file their PCT applications through the EPO or WIPO instead. The office coordinates with the EPO and supports the Benelux Patent Platform. For a portfolio owner, knowing which international applications ran through which authority matters, because the quality and timing of that first search shapes how a family matures and how defensible it looks when a licensee, buyer or opponent later scrutinises it.

Renewals are where an unmanaged estate bleeds cash. National and classic validated European patents carry annuities that escalate every year; a unitary patent carries a single renewal fee paid to the EPO. A pruning analysis scores every family before its next renewal against three tests — does it still cover a product or roadmap item, does it block a competitor, and would a licensee or buyer pay for it. For a large research-institute or spin-out estate that single exercise usually pays for the whole review, and it also catches the opposite error: a strategic family drifting toward a lapse that costs far more than the fee saved.

How PerspireIP builds a portfolio analysis you can act on

Every engagement follows the same disciplined path, scaled to whether you are clearing a process node, prepping a data room, defending a budget or planning next year’s filings. We inventory the portfolio, verify legal status and the often-shared ownership chain, map each asset to products and competitors, grade strength, essentiality and UPC exposure, and price the estate for the decision that prompted the review.

• Full inventory with legal status, term and renewal timeline for every asset across the OPRI, EPO and unitary routes
• Ownership and encumbrance mapping for co-invented imec, KU Leuven and consortium families
• Product-to-patent coverage mapping and a claim-strength score across the estate
• Freedom-to-operate landscaping across the major semiconductor, nanoelectronics and photonics assignees
• UPC opt-out grading and a Brussels Local Division versus Brussels Enterprise Court forum map for every family
• Renewal-fee pruning recommendations plus a valuation view for financing, M&A or licensing, delivered as data-room-ready exhibits

We work alongside your in-house IP team, technology-transfer office or outside counsel as a specialist analysis partner, deliver to your licensing or budget calendar, and keep every engagement confidential. Whether you need a one-time diligence study before a Leuven spin-out raise, a freedom-to-operate read for a new semiconductor programme, or an annual portfolio health check for the board, we scale to fit. Send us the assignee name or a patent list and we will scope a patent portfolio analysis Leuven project within one business day.

IP Landscape & Resources in Leuven

Key intellectual-property authorities and venues relevant to Leuven:

• Belgian Office for Intellectual Property (OPRI/DIE) — the intellectual-property office within the Federal Public Service Economy that grants Belgian national patents, keeps the national register and coordinates with the EPO
• Unified Patent Court — the court whose Brussels Local Division, seated at the FPS Economy, decides pan-European infringement and revocation actions in Dutch, German, French or English
• European Patent Office (EPO) — grants the European and unitary patents that make up most of a Belgian deep-tech portfolio and sets the unitary renewal-fee schedule
• imec — the world's largest independent nanoelectronics research centre, headquartered in Leuven, whose 1,600-plus patent families anchor the region's semiconductor IP

Request a Patent Portfolio Analysis in Leuven

Explore related PerspireIP services: Patent Portfolio Analysis services · IP services in Belgium · patent invalidation · prior art and litigation search · patent infringement analysis · patent monetization.

Frequently Asked Questions